Hyperuricemia and metabolic syndrome in type 2 diabetes mellitus patients at Hawassa university comprehensive specialized hospital, South West Ethiopia

Abstract Background Metabolic syndrome is a cluster of the most dangerous heart attack risk factors such as diabetes and prediabetes, abdominal obesity, high cholesterol and high blood pressure. Hyperuricemia is a condition in which the serum uric acid concentration is greater than 5.5 mg per decili...

Full description

Bibliographic Details
Main Authors: Shiferaw Bekele Woyesa, Agete Tadewose Hirigo, Temesgen Bizuayehu Wube
Format: Article
Language:English
Published: BMC 2017-12-01
Series:BMC Endocrine Disorders
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12902-017-0226-y
_version_ 1818972625269948416
author Shiferaw Bekele Woyesa
Agete Tadewose Hirigo
Temesgen Bizuayehu Wube
author_facet Shiferaw Bekele Woyesa
Agete Tadewose Hirigo
Temesgen Bizuayehu Wube
author_sort Shiferaw Bekele Woyesa
collection DOAJ
description Abstract Background Metabolic syndrome is a cluster of the most dangerous heart attack risk factors such as diabetes and prediabetes, abdominal obesity, high cholesterol and high blood pressure. Hyperuricemia is a condition in which the serum uric acid concentration is greater than 5.5 mg per deciliter for child and greater than 7.2 and 6.0 mg per deciliters for male and female adults respectively. Methods A cross-sectional study was conducted to determine the magnitude of hyperuricemia and associated factors among type 2 diabetes mellitus patients at Hawassa Comprehensive Specialized Hospital (HCSH) from February 28 to May 30 /2017. A random sampling technique was used to include 319 study subjects and a signed consent had been provided by each study subject before running any data collection. An interviewer administered structured questionnaire was used to collect socio-demographic and some clinically useful data. In addition to this, we reviewed the records of the study subjects to obtain other useful clinical data. Five milliliter blood specimen was collected from each study subjects after overnight fasting. A25TM Bio-System Random Access chemistry analyzer was used for blood sample analysis. All data were checked visually, coded and entered into epi-data version 3.4 and statistical analysis was performed using SPSS version 20.0 software. Bi-variate and multivariate logistic regressions were used to determine the association between explanatory and the outcome variables. Results The prevalence of hyperuricemia and metabolic syndrome among type 2 diabetic patients in the study area were 33.8%(n = 106) and 70.1% (n = 220) respectively. Having age greater or equal to 45 years (AOR: 1.9, CI: 1.-3.2, P value =0.015) and having metabolic syndrome (AOR: 2.6, CI: 1.5–4.7, P value = 0.001) were the determinant variables for hyperuricemia among type 2 diabetic patients. Conclusion There was high prevalence of hyperuricemia among type 2 diabetic patients with high prevalence of metabolic syndrome. Therefore, regular health information about life style modification, early diagnosis and treatment for hyperuricemia and metabolic syndrome are essential to reduce hyperuricemia and metabolic syndrome in type 2 diabetic patients.
first_indexed 2024-12-20T15:11:14Z
format Article
id doaj.art-f809b0e0a36e4b09ad9667052b2beff6
institution Directory Open Access Journal
issn 1472-6823
language English
last_indexed 2024-12-20T15:11:14Z
publishDate 2017-12-01
publisher BMC
record_format Article
series BMC Endocrine Disorders
spelling doaj.art-f809b0e0a36e4b09ad9667052b2beff62022-12-21T19:36:20ZengBMCBMC Endocrine Disorders1472-68232017-12-011711810.1186/s12902-017-0226-yHyperuricemia and metabolic syndrome in type 2 diabetes mellitus patients at Hawassa university comprehensive specialized hospital, South West EthiopiaShiferaw Bekele Woyesa0Agete Tadewose Hirigo1Temesgen Bizuayehu Wube2School of Medical Laboratory Sciences, Institute of Health Sciences, Jimma UniversityHawasa UniversityHawasa UniversityAbstract Background Metabolic syndrome is a cluster of the most dangerous heart attack risk factors such as diabetes and prediabetes, abdominal obesity, high cholesterol and high blood pressure. Hyperuricemia is a condition in which the serum uric acid concentration is greater than 5.5 mg per deciliter for child and greater than 7.2 and 6.0 mg per deciliters for male and female adults respectively. Methods A cross-sectional study was conducted to determine the magnitude of hyperuricemia and associated factors among type 2 diabetes mellitus patients at Hawassa Comprehensive Specialized Hospital (HCSH) from February 28 to May 30 /2017. A random sampling technique was used to include 319 study subjects and a signed consent had been provided by each study subject before running any data collection. An interviewer administered structured questionnaire was used to collect socio-demographic and some clinically useful data. In addition to this, we reviewed the records of the study subjects to obtain other useful clinical data. Five milliliter blood specimen was collected from each study subjects after overnight fasting. A25TM Bio-System Random Access chemistry analyzer was used for blood sample analysis. All data were checked visually, coded and entered into epi-data version 3.4 and statistical analysis was performed using SPSS version 20.0 software. Bi-variate and multivariate logistic regressions were used to determine the association between explanatory and the outcome variables. Results The prevalence of hyperuricemia and metabolic syndrome among type 2 diabetic patients in the study area were 33.8%(n = 106) and 70.1% (n = 220) respectively. Having age greater or equal to 45 years (AOR: 1.9, CI: 1.-3.2, P value =0.015) and having metabolic syndrome (AOR: 2.6, CI: 1.5–4.7, P value = 0.001) were the determinant variables for hyperuricemia among type 2 diabetic patients. Conclusion There was high prevalence of hyperuricemia among type 2 diabetic patients with high prevalence of metabolic syndrome. Therefore, regular health information about life style modification, early diagnosis and treatment for hyperuricemia and metabolic syndrome are essential to reduce hyperuricemia and metabolic syndrome in type 2 diabetic patients.http://link.springer.com/article/10.1186/s12902-017-0226-yHyperuricemiaMetabolic syndromeHawassaEthiopia
spellingShingle Shiferaw Bekele Woyesa
Agete Tadewose Hirigo
Temesgen Bizuayehu Wube
Hyperuricemia and metabolic syndrome in type 2 diabetes mellitus patients at Hawassa university comprehensive specialized hospital, South West Ethiopia
BMC Endocrine Disorders
Hyperuricemia
Metabolic syndrome
Hawassa
Ethiopia
title Hyperuricemia and metabolic syndrome in type 2 diabetes mellitus patients at Hawassa university comprehensive specialized hospital, South West Ethiopia
title_full Hyperuricemia and metabolic syndrome in type 2 diabetes mellitus patients at Hawassa university comprehensive specialized hospital, South West Ethiopia
title_fullStr Hyperuricemia and metabolic syndrome in type 2 diabetes mellitus patients at Hawassa university comprehensive specialized hospital, South West Ethiopia
title_full_unstemmed Hyperuricemia and metabolic syndrome in type 2 diabetes mellitus patients at Hawassa university comprehensive specialized hospital, South West Ethiopia
title_short Hyperuricemia and metabolic syndrome in type 2 diabetes mellitus patients at Hawassa university comprehensive specialized hospital, South West Ethiopia
title_sort hyperuricemia and metabolic syndrome in type 2 diabetes mellitus patients at hawassa university comprehensive specialized hospital south west ethiopia
topic Hyperuricemia
Metabolic syndrome
Hawassa
Ethiopia
url http://link.springer.com/article/10.1186/s12902-017-0226-y
work_keys_str_mv AT shiferawbekelewoyesa hyperuricemiaandmetabolicsyndromeintype2diabetesmellituspatientsathawassauniversitycomprehensivespecializedhospitalsouthwestethiopia
AT agetetadewosehirigo hyperuricemiaandmetabolicsyndromeintype2diabetesmellituspatientsathawassauniversitycomprehensivespecializedhospitalsouthwestethiopia
AT temesgenbizuayehuwube hyperuricemiaandmetabolicsyndromeintype2diabetesmellituspatientsathawassauniversitycomprehensivespecializedhospitalsouthwestethiopia